# US 2012/0253189 A1 · Cavity-filling biopsy site markers

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0253189 A1
- Document ID: US20120253189A1
- Status: Published application
- Kind: A1
- Application number: 13/495,408
- Filed: 2012-06-13
- Published: 2012-10-04
- Earliest claimed: 1999-02-02
- Assignees: SenoxRx, Inc.
- Inventors: Fred H. Burbank; Paul Lubock; Michael L. Jones
- Web page: https://patentgrep.com/patent/US20120253189A1

## CPC

- A61B 8/481: {involving the use of contrast agents, e.g. microbubbles introduced into the bloodstream}
- A61B 90/39: {Markers, e.g. radio-opaque or breast lesions markers}
- A61K 49/006: {Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery}
- A61K 49/222: {characterised by a special physical form, e.g. emulsions, liposomes}
- A61M 37/0069: {Devices for implanting pellets, e.g. markers or solid medicaments (for introducing of radioactive sources for interstitial radiation therapy, i.e. brachytherapy A61N5/1027)}
- A61B 6/12: Arrangements for detecting or locating foreign bodies
- A61B 8/0833: {involving detecting or locating foreign bodies or organic structures}
- A61B 10/02: Instruments for taking cell samples or for biopsy {(A61B10/0038 and A61B10/0045 take precedence; needle locating or guiding means A61B17/3403; samplers for enzymology or microbiology C12M1/26; sampling or preparing biological specimens G01N33/48)}
- A61B 2017/00004: {(bio)absorbable, (bio)resorbable or resorptive}
- A61B 2090/3908: {Soft tissue, e.g. breast tissue}
- A61B 2090/392: {Radioactive markers}
- A61B 2090/3925: {ultrasonic}
- A61B 2090/395: {with marking agent for marking skin or other tissue}
- A61B 2090/3954: {magnetic, e.g. NMR or MRI}
- A61B 2090/3966: {Radiopaque markers visible in an X-ray image}
- A61B 2090/3987: {Applicators for implanting markers}
- A61B 2090/3995: {Multi-modality markers}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

The invention provides materials, devices and methods for marking biopsy sites for a limited time. The biopsy-marking materials are ultrasound-detectable bio-resorbable powders, with powder particles typically between about 20 microns and about 800 microns in maximum dimension, more preferably between about 300 microns and about 500 microns. The powders may be formed of polymeric materials containing cavities sized between about 10 microns and about 500 microns, and may also contain binding agents, anesthetic agents, hemostatic agents, and radiopaque markers. Devices for delivering the powders include tubes configured to contain the powders and to fit within a biopsy cannula, the powders being ejected by action of a syringe. Systems may include a tube containing powder, and a syringe containing sterile saline. The tube may be configured to fit within a biopsy cannula such as a Mammotome® or SenoCor 360™ cannula.

## Claims

### Claim 1

A marking system for delivering a marker mass into a cavity in a patient, comprising:
a delivery tube; and
an ultrasound-detectable biopsy marker mass carried by the delivery tube for delivery to the cavity, the ultrasound-detectable biopsy marker mass having a detectable in-vivo lifetime during which the marker mass remains readily detectable by ultrasound, and which is formed of particles of a bio-resorbable material having internal bubble cavities and having a particle size less than about 800 microns.

### Claim at position 2

2-75. (canceled)

### Claim 76 (depends on 1)

The marking system of claim 1, wherein the marker mass is a bio-resorbable powder mass having a volume of between about 0.2 ml and about 1.2 ml of powder.

### Claim 77 (depends on 1)

The marking system of claim 1, wherein the particle size is between about 200 microns and about 500 microns, and the bubble cavities have a size of at least 50 microns, wherein the bubble cavities have geometric centers and the bubble cavity size is measured by length through the geometric centers of the bubble cavities.

### Claim 78 (depends on 1)

The marking system of claim 1, wherein said bio-resorbable material comprises a bio-resorbable polymeric material and the particle size is between about 200 microns and about 500 microns.

### Claim 79 (depends on 1)

The marking system of claim 1, wherein at least a portion of the particles have both internal bubble cavities and have exposed surfaces of broken bubble cavities.

### Claim 80

A marking system for delivering a marker mass into a cavity in a patient, comprising:
a delivery tube; and
an ultrasound-detectable biopsy marker mass carried by the delivery tube for delivery to the cavity, the ultrasound-detectable biopsy marker mass being formed of particles of a bio-resorbable material having internal bubble cavities and having a particle size between about 200 microns and about 800 microns.

### Claim 81 (depends on 80)

The marking system of claim 80, the bubble cavities having a size of at least 50 microns, wherein the bubble cavities have geometric centers and the bubble cavity size is measured by length through the geometric centers of the bubble cavities.

### Claim 82 (depends on 80)

The marking system of claim 80, wherein said bio-resorbable material comprises a bio-resorbable polymeric material.

### Claim 83 (depends on 80)

The marking system of claim 80, wherein at least a portion of the particles have both internal bubble cavities and have exposed surfaces of broken bubble cavities.

### Claim 84

In a marking system for delivering a marker mass into a cavity in a patient via a delivery tube, the marker mass comprising a bolus of biopsy marker powder which is ultrasonically detectable in-vivo within a patient's biopsy site for a period of at least two weeks but not longer than six months, which comprises a comminuted bio-resorbable polymeric powdered material, at least a portion of the comminuted powder having particles with a particle size of about 200 to about 800 microns and the particles of the comminuted powder having one or more bubble cavities within the particles smaller than the particle size of the particles.

### Claim 85 (depends on 84)

The marker mass of claim 84, wherein the portion of the comminuted powder has a particle size between about 300 microns and about 500 microns.

### Claim 86 (depends on 84)

The marker mass of claim 84, wherein the comminuted powder comprises about 65% by weight polylactic acid and about 35% by weight polyglycolic acid.

### Claim 87 (depends on 84)

The marker mass of claim 84, wherein at least some of the particles have both internal bubble cavities and have exposed surfaces of broken bubble cavities.

### Claim 88 (depends on 84)

The marker mass of claim 84, having an ultrasonically detectable in-vivo lifetime of not greater than about 20 weeks.

### Claim 89 (depends on 84)

The marker mass of claim 84, having an ultrasonically detectable in-vivo lifetime between about 6 weeks and about 12 weeks.

### Claim 90 (depends on 84)

The marker mass of claim 84, wherein the particles are held together with a binding agent.

### Claim 91 (depends on 90)

The marker mass of claim 90, wherein the binding agent is selected from the group consisting of gelatin, polyethylene glycol, polyvinyl alcohol, glycerine, acrylic hydrogels, organic hydrogels, and combinations thereof.

### Claim 92 (depends on 90)

The marker mass of claim 90, wherein the binding agent is selected from the group consisting of bovine collagen, porcine collagen, ovine collagen, equine collagen, synthetic collagen, agar, synthetic gelatin, and combinations thereof.

### Claim 93 (depends on 84)

The marker mass of claim 84, comprising one part gelatin and about five parts comminuted bio-resorbable polymeric material, the particles of the comminuted material having bubble cavities about 50 to about 200 microns in size.

### Claim 94 (depends on 84)

The marker mass of claim 84, comprising about one part gelatin to about three parts polymeric material.
